We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Metabasis Therapeutics Extends Collaboration with Merck to Develop AMPK Activators for Diabetes and Other Metabolic Diseases

News   Apr 24, 2008

 
Metabasis Therapeutics Extends Collaboration with Merck to Develop AMPK Activators for Diabetes and Other Metabolic Diseases
 
 
 

RELATED ARTICLES

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

Rare and Undiagnosed Conditions Get Massive Research Funding Boost

News

Five new clinical sites, a new metabolomics core, and increased model organism capabilities among additions.

READ MORE

Simulations Enable 'Choose-your-own-Adventure' Stereochemistry

News

Stereochemistry is a science of reflection. Two chemical molecules with the same composition and structure, but with one as the mirror image of the other, can produce wildly varying effects. But University of Utah chemist Matt Sigman has been developing a way to get a better grasp on this tricky field of chemistry.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE